NCT00239135View on ClinicalTrials.gov

Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel

PHASE2CompletedINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

Keratosis

Interventions

DRUG

PEP005

Trial Locations (1)

75703

Dermatology Associates of Tyler, Tyler

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Peplin

INDUSTRY

NCT00239135 - Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel | Biotech Hunter | Biotech Hunter